4Filed Aug 4, 8:00 PM ET

Life360 (LIF) Director John Coghlan Sells 4,000 Shares

$LIF · Life360, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Life360 (LIF) Director John Coghlan Sells 4,000 Shares

What Happened
John Philip Coghlan, a director of Life360, sold a total of 4,000 shares of Life360 common stock in open-market transactions on August 3, 2026. The sales consisted of 1,400 shares at a weighted average price of $54.66 (proceeds $76,524) and 2,600 shares at a weighted average price of $54.90 (proceeds $142,740), for combined gross proceeds of approximately $219,264. These were sales (not purchases), which are often routine dispositions rather than a directional endorsement of the stock.

Key Details

  • Transaction date: August 3, 2026; Form 4 filed August 5, 2026 (appears timely).
  • Prices: 1,400 shares at weighted avg $54.66 (individual trades ranged $53.83–$54.80); 2,600 shares at weighted avg $54.90 (individual trades ranged $54.89–$54.95).
  • Total shares sold: 4,000; total reported proceeds ≈ $219,264.
  • Shares owned after transaction: not specified in the provided summary; filing notes ownership includes 4,840 restricted stock units (RSUs) that convert to shares upon vesting (see footnote F4).
  • Transaction was effected pursuant to a Rule 10b5‑1 trading plan adopted by Coghlan on December 8, 2025 (pre-arranged plan; footnote F1).
  • The filing discloses weighted-average prices and price ranges; the reporter offers to provide full per-trade details on request (footnotes F2 and F3).

Context
A Rule 10b5‑1 plan lets insiders sell (or buy) shares automatically according to a preset formula and timing, and is commonly used to avoid trading on material nonpublic information. Such planned sales are typically considered routine liquidity transactions rather than signals about company fundamentals. The RSUs noted are contingent rights to receive shares upon vesting and are not immediately tradable.